Health
U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…
By Reuters Staff
FILE PHOTO: A sign at an AstraZeneca site in Macclesfield, Britain, May 19, 2014. REUTERS/Phil Noble/File Photo
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very signif…
-
General12 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
Noosa News18 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
General24 hours agoLegal experts, civil libertarians warn the NSW government is ‘eroding’ the right to protest